Millions of heart patients whose disease has been treated with stents may need to stay on an aggressive course of blood-thinning drugs longer than current practice, a new study suggests.
from WSJ.com: US Business http://ift.tt/1uFlGSm
via IFTTT
from WSJ.com: US Business http://ift.tt/1uFlGSm
via IFTTT
No comments:
Post a Comment